Key result
Novel CARMAT TAH undergoes feasibility testing with clinical results pending study completion.
Design
Review
Authors
Loading...
Long-term TAH support feasible in select cases; leaves open durability, complications, and broader destination-therapy role.
The CARMAT TAH introduces bioprosthetic materials and autoregulated internal actuation to total artificial heart design, aiming to improve hemocompatibility and quality of life.
Mohaçsi et al. (2014) conducted a review in Heart failure requiring total artificial heart. CARMAT total artificial heart was evaluated. The CARMAT total artificial heart is a novel bioprosthetic device currently undergoing a feasibility clinical trial, with clinical results to be communicated after study completion.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: